BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Immunology Podcast - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The Immunology Podcast
X-ORIGINAL-URL:https://www.immunologypodcast.com
X-WR-CALDESC:Events for The Immunology Podcast
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240504T123000
DTEND;TZID=America/New_York:20240504T140000
DTSTAMP:20260427T040722
CREATED:20240327T160048Z
LAST-MODIFIED:20240617T211109Z
UID:5625-1714825800-1714831200@www.immunologypodcast.com
SUMMARY:The Immunology Podcast Presents: Artificial Intelligence and Immunology
DESCRIPTION:Join the Immunology Podcast for a live show at IMMUNOLOGY2024™! Brenda and Jason will chat with Drs. Jo Viney and Ryan Peckner from Seismic Therapeutic about how artificial intelligence is being used in immunology research. They will discuss how AI is contributing to innovations in the field\, including the use of machine learning in drug development. \nDate: May 4\, 2024\nTime: 12:30 – 2:00 p.m. EDT\nLocation: McCormick Place Convention Center\, Room W180 \nGuests:\nJo Viney\, PhD\nCEO\, President\, Co-Founder\, Seismic Therapeutic\nRyan Peckner\, PhD\nDirector of Machine Learning and Computational Biology\, Seismic Therapeutic\n\n\nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/the-immunology-podcast-presents-artificial-intelligence-and-immunology
LOCATION:McCormick Place Convention Center\, 2301 S Martin Luther King Dr\, Chicago\, IL\, 60616\, United States
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2024/03/Jo-and-Ryan-420-px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240423
DTEND;VALUE=DATE:20240424
DTSTAMP:20260427T040722
CREATED:20240325T171649Z
LAST-MODIFIED:20240427T064005Z
UID:5629-1713830400-1713916799@www.immunologypodcast.com
SUMMARY:Dr. Caleb Lareau
DESCRIPTION:Dr. Caleb Lareau is an Assistant Professor at Memorial Sloan Kettering Cancer Center. His team of interdisciplinary scientists specializes in computational and translational immunology. Specifically\, they develop and utilize single-cell multi-omics technologies and computational biology to study human hematopoietic system as how immune cells change as we age and are exposed to pathogens\, including endemic viruses. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-caleb-lareau
LOCATION:IL
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2024/03/Caleb-Lareau-420-px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240409
DTEND;VALUE=DATE:20240410
DTSTAMP:20260427T040722
CREATED:20240315T222703Z
LAST-MODIFIED:20240427T065232Z
UID:5618-1712620800-1712707199@www.immunologypodcast.com
SUMMARY:Dr. Mitchell Kronenberg
DESCRIPTION:Dr. Mitchell Kronenberg is a Professor and President Emeritus at La Jolla Institute for Immunology. He and his team study study innate-like T lymphocytes\, including natural killer T cells\,  mucosal-associated invariant T cells\, and gd T cells\, as well as innate lymphoid cells. They are also interested in mucosal immunology and the development of inflammatory bowel diseases. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-mitchell-kronenberg
LOCATION:IL
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2024/03/Mitch-Kronenberg.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240326
DTEND;VALUE=DATE:20240327
DTSTAMP:20260427T040722
CREATED:20240315T222114Z
LAST-MODIFIED:20240315T222141Z
UID:5614-1711411200-1711497599@www.immunologypodcast.com
SUMMARY:Dr. Scott Canna
DESCRIPTION:Dr. Scott Canna is an  Associate Professor of Pediatrics (Rheumatology) and Attending Physician\, Pediatric Rheumatology and Immune Dysregulation at the Children’s Hospital of Philadelphia. Dr. Canna’s group studies the intersections of hyper- and auto-inflammation. In particular\, they study two related disorders\, Hemophagocytic Lymphohistiocytosis (HLH) and Macrophage Activation Syndrome\, because they typify the concept of hyperinflammation. They combine clinical insights from rheumatology and innate immunity with basic models of overwhelming systemic inflammation to define new disease subtypes and disease activity biomarkers\, to flesh out mechanisms of inflammatory disease\, and to test promising therapeutic strategies.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-scott-canna
LOCATION:IL
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/03/Scott-Canna-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240312
DTEND;VALUE=DATE:20240313
DTSTAMP:20260427T040722
CREATED:20240208T185231Z
LAST-MODIFIED:20240208T185231Z
UID:5563-1710201600-1710287999@www.immunologypodcast.com
SUMMARY:Dr. Neelika Malavige
DESCRIPTION:Dr. Neelika Malavige is a well-recognized leader in the field of dengue. She is the Head of Dengue Global Programme and Scientific Affairs at DNDi. She is also a Professor at the University of Sri Jayewardenepura. She previously was Head of the Department of Immunology and Molecular Medicine\, where her research focus on dengue was to find out the therapeutic targets\, notably mediators of vascular leak\, the role of antibodies in disease pathogenesis\, and correlates of protection in dengue.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-neelika-malavige
LOCATION:IL
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2024/02/Neelika-420px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240227
DTEND;VALUE=DATE:20240228
DTSTAMP:20260427T040722
CREATED:20240131T181450Z
LAST-MODIFIED:20240228T024043Z
UID:5548-1708992000-1709078399@www.immunologypodcast.com
SUMMARY:Dr. James Allison
DESCRIPTION:Dr. James Allison is Regental Professor and Chair of the Department of Immunology\, the Olga Keith Wiess Distinguished University Chair for Cancer Research\, Director of the Parker Institute for Cancer Research\, Executive Director of the Immunotherapy Platform\, and Director of the James P. Allison Institute at MD Anderson Cancer Center. He has spent a distinguished career studying the regulation of T cell responses and developing strategies for cancer immunotherapy. He earned the 2018 Nobel Prize in Physiology or Medicine\, which he shared with Dr. Tasuku Honjo\, “for their discovery of cancer therapy by inhibition of negative immune regulation.” \nAmong his most notable discoveries are the determination of the T cell receptor structure and that CD28 is the major costimulatory molecule that allows full activation of naïve T cells and prevents anergy in T cell clones. His lab resolved a major controversy by demonstrating that CTLA-4 inhibits T-cell activation by opposing CD28-mediated costimulation and that blockade of CTLA-4 could enhance T cell responses\, leading to tumor rejection in animal models. This finding and a great deal of persistence paved the way for the field of immune checkpoint blockade therapy for cancer. \nWork in his lab led to the development of ipilimumab\, an antibody to human CTLA-4 and the first immune checkpoint blockade therapy approved by the FDA. Among many honors\, he is a member of the National Academies of Science and Medicine and received the Lasker-Debakey Clinical Medical Research award in 2015. His current work seeks to improve immune checkpoint blockade therapies currently used by our clinicians and identify new targets to unleash the immune system in order to eradicate cancer. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-james-allison
LOCATION:IL
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/01/James-Allison-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240213
DTEND;VALUE=DATE:20240214
DTSTAMP:20260427T040722
CREATED:20240207T170631Z
LAST-MODIFIED:20240207T170631Z
UID:5555-1707782400-1707868799@www.immunologypodcast.com
SUMMARY:Dr. Akiko Iwasaki\, Francisco Gomez-Rivera\, and Dr. Jason Augustine
DESCRIPTION:  \nDr. Akiko Iwasaki is the Sterling Professor of Immunobiology and Molecular\, Cellular\, and Developmental Biology at Yale University. Francisco Gomez-Rivera is an Immunology Program Graduate Student Candidate at the University of Michigan. Dr. Jason Augustine has retired recently from his position as a Research Microbiologist/Immunologist at the US Environmental Protection Agency. \nThis episode will focus on the upcoming IMMUNOLOGY2024 meeting taking place in Chicago\, May 3-7.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-akiko-iwasaki-francisco-gomez-rivera-and-dr-jason-augustine
LOCATION:IL
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/02/IMMUNOLOGY2024.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240130
DTEND;VALUE=DATE:20240131
DTSTAMP:20260427T040722
CREATED:20240110T171504Z
LAST-MODIFIED:20240208T183629Z
UID:5515-1706572800-1706659199@www.immunologypodcast.com
SUMMARY:Dr. Dionna Williams
DESCRIPTION:Dr. Dionna Williams is an Assistant Professor of Molecular and Comparative Pathobiology at Johns Hopkins School of Medicine. Their research interests are in the neuropathogenesis of HIV\, regulatory mechanisms of neuroimmune signaling\, drug delivery to the central nervous system\, and immunologic and pharmacologic contributors to health disparities. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-dionna-williams
LOCATION:IL
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/01/Dionna-Williams-420px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240116
DTEND;VALUE=DATE:20240117
DTSTAMP:20260427T040722
CREATED:20240112T214632Z
LAST-MODIFIED:20240119T201836Z
UID:5521-1705363200-1705449599@www.immunologypodcast.com
SUMMARY:Drs. Akiko Iwasaki and Aimee Bernard
DESCRIPTION:Dr. Akiko Iwasaki is the Sterling Professor of Immunobiology and Molecular\, Cellular\, and Developmental Biology at Yale University. Her research focuses on the mechanisms of immune defense against viruses at the mucosal surfaces\, and the development of mucosal vaccine strategies. She is active on social media and works to combat mis- and disinformation surrounding science. \nDr. Aimee Bernard is an Assistant Professor of Immunology and Microbiology at the University of Colorado. As a faculty mentor\, she guides a group of volunteer graduate students from all across campus to run a non-profit\, after-school science program – Think Like a Scientist. In her role as the Executive Director of the Human Immunology and Immunotherapy Initiative (HI3) Aimee coordinates the development of the research and clinical infrastructure necessary to create an all-inclusive\, premier facility for the discovery and use of human immunotherapies for the treatment of cancer and autoimmune diseases. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/drs-akiko-iwasaki-and-aimee-bernard
LOCATION:IL
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2024/01/Akiko-and-Aimee-update-420-px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231107
DTEND;VALUE=DATE:20231108
DTSTAMP:20260427T040722
CREATED:20231029T190558Z
LAST-MODIFIED:20231029T190610Z
UID:5426-1699315200-1699401599@www.immunologypodcast.com
SUMMARY:Dr. Sophia Liu
DESCRIPTION:Dr. Sophia Liu is a Core Faculty Member and Early Independence Fellow at the Ragon Institute of Mass General\, MIT\, and Harvard. She enjoys creating new ways to measure temporally and spatially dynamic cell interactions and is particularly interested in studying T and B-cell development. Her lab’s research focuses on immune cell interactions in tissues and dynamics across immune development and aging.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-sophia-liu
LOCATION:IL
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2023/10/Sophia-Liu-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231010
DTEND;VALUE=DATE:20231011
DTSTAMP:20260427T040722
CREATED:20230915T061846Z
LAST-MODIFIED:20230915T062011Z
UID:5388-1696896000-1696982399@www.immunologypodcast.com
SUMMARY:Dr. Peter Fecci
DESCRIPTION:Dr. Peter Fecci is a Professor of Neurosurgery and the Director of the Center for Brain and Spine Metastasis at Duke University. His research centers around brain tumor immunology and immunotherapy\, and T cell dysfunction in glioblastoma and other intracranial cancers.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-peter-fecci
LOCATION:IL
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2023/09/Peter-Fecci-square-crop.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230912
DTEND;VALUE=DATE:20230913
DTSTAMP:20260427T040722
CREATED:20230815T054339Z
LAST-MODIFIED:20230815T055823Z
UID:5327-1694476800-1694563199@www.immunologypodcast.com
SUMMARY:Dr. Kristin Anderson
DESCRIPTION:Dr. Kristin Anderson is an Assistant Professor at the University of Virginia. Her research program develops engineered T cell immunotherapies\, integrating cellular and molecular techniques with in vivo mouse models and in vitro patient-based models of solid tumors to study the complex interactions between antitumor T cells and the tumor microenvironment.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-kristin-anderson
LOCATION:IL
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2023/08/Kristin-Anderson-420px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230829
DTEND;VALUE=DATE:20230830
DTSTAMP:20260427T040722
CREATED:20230823T222314Z
LAST-MODIFIED:20230823T222358Z
UID:5339-1693267200-1693353599@www.immunologypodcast.com
SUMMARY:Dr. Vinod Balachandran
DESCRIPTION:Dr. Vinod Balachandran is an Attending Surgeon at Memorial Sloan Kettering Cancer Center and a Member of the David. M Rubenstein Center for Pancreatic Cancer Research. His lab aims to discover new ways to stimulate the immune system to treat cancer through careful study of rare cancer patients with exceptional outcomes. They specifically focus on a rare subgroup of pancreatic cancer patients with exceptional long-term survival to discover new immunotherapeutic approaches.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-vinod-balachandran
LOCATION:IL
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2023/08/Vinod-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230815
DTEND;VALUE=DATE:20230816
DTSTAMP:20260427T040722
CREATED:20230811T204809Z
LAST-MODIFIED:20230823T175156Z
UID:5320-1692057600-1692143999@www.immunologypodcast.com
SUMMARY:Dr. Greg Delgoffe
DESCRIPTION:Dr. Greg Delgoffe is an Associate Professor at the University of Pittsburgh. The Delgoffe lab studies the intersection of metabolism and immunity in cancer. Specifically\, they investigate how tumor cells deplete their local microenvironment of nutrients\, effectively starving tumor-infiltrating T cells and preventing their function. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-greg-delgoffe
LOCATION:IL
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2023/08/Greg-Delgoffe-420-px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230801
DTEND;VALUE=DATE:20230802
DTSTAMP:20260427T040722
CREATED:20230713T221747Z
LAST-MODIFIED:20230713T221818Z
UID:5302-1690848000-1690934399@www.immunologypodcast.com
SUMMARY:Dr. Daniel Streicker
DESCRIPTION:Dr. Daniel Streicker is a Professor of Viral Ecology at the University of Glasgow. His lab uses a range of approaches to identify patterns in pathogen transmission between species\, and develop solutions for real-world disease problems. Current projects are investigating transmissible and transferrable vaccines for disease control in bats\, prediction of the host tropism of viruses from their genome sequences\, understanding how satellite viruses jump between host species\, and forecasting vampire bat rabies outbreaks in humans and livestock.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-daniel-streicker
LOCATION:IL
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2023/07/Daniel-Streicker-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230718
DTEND;VALUE=DATE:20230719
DTSTAMP:20260427T040722
CREATED:20230712T233406Z
LAST-MODIFIED:20230712T233419Z
UID:5294-1689638400-1689724799@www.immunologypodcast.com
SUMMARY:Dr. Jamie Spangler
DESCRIPTION:Dr. Jamie Spangler is an Assistant Professor in the Departments of Biomedical and Chemical & Biomolecular Engineering at Johns Hopkins University. Her group aims to redesign existing proteins and engineer new proteins that overcome these limitations. Combining cutting-edge technologies from structural biophysics\, molecular engineering\, and translational immunology\, they create new platforms for the development of targeted therapeutics to treat a broad range of immune diseases.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-jamie-spangler
LOCATION:IL
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2023/07/Jamie-Spangler-square-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230621
DTEND;VALUE=DATE:20230622
DTSTAMP:20260427T040722
CREATED:20230504T163917Z
LAST-MODIFIED:20230621T165009Z
UID:5188-1687305600-1687391999@www.immunologypodcast.com
SUMMARY:Dr. Alessandro Sette
DESCRIPTION:Dr. Alessandro Sette has devoted more than 35 years of study towards understanding the immune response\, measuring immune activity\, and developing disease intervention strategies against cancer\, autoimmunity\, allergy\, and infectious diseases. The laboratory is defining in chemical terms the specific structures (epitopes) that the immune system recognizes\, and uses this knowledge to measure and understand immune responses. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-alessandro-sette
LOCATION:IL
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2023/05/Alex-Sette-square-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230509
DTEND;VALUE=DATE:20230510
DTSTAMP:20260427T040722
CREATED:20230504T183230Z
LAST-MODIFIED:20230504T183309Z
UID:5192-1683590400-1683676799@www.immunologypodcast.com
SUMMARY:Dr. Prasanna Jagannathan
DESCRIPTION:Dr. Prasanna Jagannathan is an Assistant Professor of Medicine at Stanford University. His research program in human immunology focuses on malaria-specific immune responses in pregnancy and infancy. His current research program is to further our understanding of the mechanisms of clinical immunity to malaria through field-based studies\, and to better understand the immunologic consequences of malaria control interventions.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-prasanna-jagannathan
LOCATION:IL
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2023/05/Prasanna-Jagannathan.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230425
DTEND;VALUE=DATE:20230426
DTSTAMP:20260427T040722
CREATED:20230324T162322Z
LAST-MODIFIED:20230504T163608Z
UID:5061-1682380800-1682467199@www.immunologypodcast.com
SUMMARY:Dr. Joshua Brody
DESCRIPTION:Dr. Joshua Brody is the Director of the Lymphoma Immunotherapy Program at Icahn School of Medicine at Mount Sinai. the Brody Lab studies basic and applied tumor immunology for the development of cancer immunotherapies\, particularly for lymphomas and melanomas. They aim to improve cancer vaccines by priming anti-tumor responses at the tumor site of each patient (in situ vaccine). \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-joshua-brody
LOCATION:IL
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2023/03/Joshua-Brody-420px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230411
DTEND;VALUE=DATE:20230412
DTSTAMP:20260427T040722
CREATED:20230406T190047Z
LAST-MODIFIED:20230412T191026Z
UID:5077-1681171200-1681257599@www.immunologypodcast.com
SUMMARY:Dr. Douglas Green
DESCRIPTION:Dr. Douglas Green is the Peter C. Doherty Endowed Chair of Immunology at St. Jude Children’s Research Hospital. The Green lab asks fundamental questions about the journey of cells – how do cells live and die\, and how do these processes affect the body? Their work uses multiple -omics-based approaches as well as computational tools to try to answer these questions. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-douglas-green
LOCATION:IL
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2023/04/Doug-Green-square.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230328
DTEND;VALUE=DATE:20230329
DTSTAMP:20260427T040722
CREATED:20230309T203040Z
LAST-MODIFIED:20230329T213050Z
UID:5043-1679961600-1680047999@www.immunologypodcast.com
SUMMARY:Drs. Miriam Merad and Mark Davis
DESCRIPTION:Dr. Miriam Merad is the President and Dr. Mark Davis is a Scientific Programme Committee Co-Chair of the International Union of Immunological Societies (IUIS). This episode focuses on the upcoming 18th International Congress of Immunology taking place November 27 – December 2 in Capetown\, South Africa. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/drs-miriam-merad-and-mark-davis
LOCATION:IL
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2023/03/Miriam-Merad-and-Mark-Davis.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230314
DTEND;VALUE=DATE:20230315
DTSTAMP:20260427T040722
CREATED:20230309T182511Z
LAST-MODIFIED:20230315T211456Z
UID:5032-1678752000-1678838399@www.immunologypodcast.com
SUMMARY:Dr. Clovis Palmer
DESCRIPTION:Dr. Clovis Palmer is an Assistant Professor at Tulane University. He uses non-human primate models to study aging\, long-COVID\, and HIV. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-clovis-palmer
LOCATION:IL
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2023/03/Clovis-Palmer.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230228
DTEND;VALUE=DATE:20230301
DTSTAMP:20260427T040722
CREATED:20230225T001224Z
LAST-MODIFIED:20230225T001850Z
UID:5005-1677542400-1677628799@www.immunologypodcast.com
SUMMARY:Drs. Mark Davis\, Daniel Mucida\, and Shruti Naik
DESCRIPTION:Dr. Mark Davis is the President of the American Association of Immunologists and the Avery Family Professor of Immunology at Stanford University. Dr. Daniel Mucida is a Professor at Rockefeller University and Dr. Shruti Naik is an Assistant Professor at NYU Langone Medical Center.  They discuss the upcoming IMMUNOLOGY2023™ meeting in May in Washington\, D.C. \n 
URL:https://www.immunologypodcast.com/upcoming-guests/drs-mark-davis-daniel-mucida-and-shruti-naik
LOCATION:IL
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2023/02/Mark-Davis-Dan-Mucida-and-Shruti-Naik-square.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230214
DTEND;VALUE=DATE:20230215
DTSTAMP:20260427T040722
CREATED:20230202T191541Z
LAST-MODIFIED:20230202T210459Z
UID:4959-1676332800-1676419199@www.immunologypodcast.com
SUMMARY:Dr. Hao Wu
DESCRIPTION:Dr. Hao Wu is the Asa and Patricia Springer Professor at Harvard Medical School. The Wu laboratory focuses on elucidating cellular and structural regulation in innate immune pathways\, in particular the inflammasome pathway.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-hao-wu
LOCATION:IL
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2022/12/hao-wu-300x300-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221025
DTEND;VALUE=DATE:20221026
DTSTAMP:20260427T040722
CREATED:20220807T220256Z
LAST-MODIFIED:20230120T171203Z
UID:4052-1666656000-1666742399@www.immunologypodcast.com
SUMMARY:Drs. Robert Watson and Kristin Patrick
DESCRIPTION:Drs. Robert Watson and Kristin Patrick’s labs at Texas A&M University College of Medicine study how the macrophage innate immune response is regulated during bacterial infection.  The Watson lab studies the Mycobacterium tuberculosis host-pathogen interface\, and is particularly focused how Mtb cytosolic access and mitochondrial homeostasis impact bacterial pathogenesis in macrophages ex vivo and in mouse models of infection. The Patrick lab studies the contributions of RNA binding proteins to macrophage activation and how post-transcriptional regulation of innate immune gene expression (mostly at the level of pre-mRNA splicing) impacts infection outcomes. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/drs-robert-watson-and-kristin-patrick
LOCATION:IL
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2022/08/20180209_Watsons_012-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221011
DTEND;VALUE=DATE:20221012
DTSTAMP:20260427T040722
CREATED:20220805T203648Z
LAST-MODIFIED:20230120T171228Z
UID:4049-1665446400-1665532799@www.immunologypodcast.com
SUMMARY:Dr. Henrique Borges da Silva
DESCRIPTION:Dr. Henrique Borges da Silva is an Assistant Professor at the Mayo Clinic in Arizona. His main research focus is determining how the extracellular nucleotide\, extracellular ATP (eATP)\, affects transcriptional\, metabolic\, and functional mechanisms of CD8-positive T cells in response to viral infections and cancer. This stems from fundamental discoveries made by Dr. Borges da Silva that showed a crucial role for the eATP purinergic receptor P2RX7 in the establishment of CD8-positive T cell memory. \nListen to the episode here. \n 
URL:https://www.immunologypodcast.com/upcoming-guests/dr-henrique-borges-da-silva
LOCATION:IL
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2022/08/Borges_da_-Silva_Henrique_20A-e1673045046528.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220927
DTEND;VALUE=DATE:20220928
DTSTAMP:20260427T040722
CREATED:20220805T201817Z
LAST-MODIFIED:20230120T171253Z
UID:4047-1664236800-1664323199@www.immunologypodcast.com
SUMMARY:Dr. Indira Mysorekar
DESCRIPTION:Dr. Indira Mysorekar is a Professor of Medicine and Chief of Basic and Translational Research at Baylor College of Medicine. She is a cell and developmental biologist with extensive training in host-microbial interactions at two distinct tissues: the urinary bladder and placenta. Her lab uses mouse and cell culture models and conducts translational studies to ask key questions about these tissues. Her research work encompasses studies of UTIs and fundamental mechanisms of urinary bladder development and homeostasis\, as well as preterm birth and in utero transmission of Zika virus. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-indira-mysorekar
LOCATION:IL
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2022/08/Indira-Mysorekar-square-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220913
DTEND;VALUE=DATE:20220914
DTSTAMP:20260427T040722
CREATED:20220901T181429Z
LAST-MODIFIED:20240924T220648Z
UID:4068-1663027200-1663113599@www.immunologypodcast.com
SUMMARY:Drs. Ruth Ley and Sara Clasen
DESCRIPTION:Dr. Ruth Ley is the Managing Director and Dr. Sara Clasen is a Postdoctoral Fellow at the Max Planck Institute for Developmental Biology Tübingen. Dr. Ley’s lab uses basic science to investigate the evolutionary history of gut microbes\, how they have adapted to life inside humans\, and how they affect human biology and health. Dr. Clasen’s research focuses on flagellin-TLR5 interactions. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/drs-ruth-ley-and-sara-clasen
LOCATION:IL
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2022/08/Ruth-Ley-and-Sara-Clasen.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220830
DTEND;VALUE=DATE:20220831
DTSTAMP:20260427T040722
CREATED:20220805T200437Z
LAST-MODIFIED:20230120T171347Z
UID:4043-1661817600-1661903999@www.immunologypodcast.com
SUMMARY:Dr. Leonardo Ferreira
DESCRIPTION:Dr. Leonardo Ferreira is an Assistant Professor of Microbiology and Immunology at the Medical University of South Carolina. The Ferreira lab uses CARs and other engineered immune receptors to dissect how specificity\, affinity\, and signaling modulate the function of different T cells subsets in tolerance and immunity. Their goal is to design and develop engineered immune cell therapies for autoimmune disease\, cancer\, and aging. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-leonardo-ferreira
LOCATION:IL
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2022/08/Leonardo-Ferreira-square.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220816
DTEND;VALUE=DATE:20220817
DTSTAMP:20260427T040722
CREATED:20220529T184859Z
LAST-MODIFIED:20230120T171741Z
UID:3990-1660608000-1660694399@www.immunologypodcast.com
SUMMARY:Dr. Karen Edelblum
DESCRIPTION:Dr. Karen Edelblum is an Assistant Professor and Chancellor Scholar at the Center for Immunity and Inflammation at Rutgers New Jersey Medical School. Her lab studies immune/epithelial interactions to better understand the underlying causes of Crohn’s disease and discover potential new areas for therapeutic development. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-karen-edelblum
LOCATION:IL
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2022/05/2021-KLE-headshot.jpg
END:VEVENT
END:VCALENDAR